Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 344articles · 30d
- 1+ day agolatest article
- Aug 14, 2026earliest in window
- 92%with images
- 291avg words
- Economy, Business & Finance 200
- Medical 159
- Health & Wellness 159
- Business & Industrial 146
- Finance & Business 135
- Health 74
- Science & Technology 53
- Science & Nature 34
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE
2+ day, 8+ hour ago (319+ words) SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference, to be…...
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
3+ day, 47+ min ago (133+ words) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first…...
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
2+ day, 20+ hour ago (194+ words) BioSpace Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief…...
Community Clinical Research Joins PhaseWell Research to Anchor Inpatient CNS Capabilities and Expand Clinical Trial Access Across Austin and Broader Texas Region
2+ day, 22+ hour ago (768+ words) BioSpace Community Clinical Research Joins PhaseWell Research to Anchor Inpatient CNS Capabilities and Expand Clinical Trial Access Across Austin and Broader Texas Region The partnership establishes Community Clinical Research as the foundation of PhaseWell’s inpatient neuropsychiatric research capabilities, deepening the…...
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
2+ day, 22+ hour ago (88+ words) — Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project — — Areas of Interest Expanded to Include Narcolepsy and Idiopathic Hypersomnia in Addition to Schizophrenia and Bipolar I Disorder — — Stage One Submission Period Runs From Sept. 11, 2026 Through Oct. 16, 2026 — Alkermes…...
Puma Biotechnology to Present at H.C. Wainwright???s 28th Annual Global Investment Conference
3+ day, 11+ hour ago (391+ words) Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference BioSpace Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman,…...
Alto Neuroscience Announces Participation in Upcoming September 2026 Investor Conferences
3+ day, 20+ hour ago (237+ words) BioSpace Alto Neuroscience Announces Participation in Upcoming September 2026 Investor Conferences MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--$anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced…...
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
3+ day, 20+ hour ago (265+ words) BioSpace Twist Bioscience to Present at Baird 2026 Global Healthcare Conference SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience,…...
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Treatment of Multiple Hematologic and Solid Malignancies
3+ day, 21+ hour ago (459+ words) BioSpace Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Treatment of Multiple Hematologic and Solid Malignancies - First-in-human TelOscope-001 study brings novel, potent, first-in-class pan-cancer T-cell engager to the clinic - - Study will assess safety, tolerability, and clinical activity…...
Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings
3+ day, 21+ hour ago (200+ words) BioSpace Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings LONDON & WARREN, N.J.--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced participation…...